Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionDynamic Technology Lab Private Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Dynamic Technology Lab Private Ltd closes position in IOVA / Iovance Biotherapeutics, Inc.

On May 15, 2026 - Dynamic Technology Lab Private Ltd filed a 13F-HR form disclosing ownership of 0 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,872 shares of Iovance Biotherapeutics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -100.00 0
2026-02-13 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 16,872 16,872 46
2025-05-16 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -17,945 -100.00 0 -100.00
2025-02-13 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 17,945 17,945 133 0.0214
2024-02-09 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -26,791 -100.00 0 0.0000
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 26,791 -86,538 -76.36 0 0.0122
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 113,329 55,881 97.27 1 0.1006
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 57,448 57,448 0 0.0324
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -43,907 -100.00 0 -100.00
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 43,907 30,464 226.62 421 184.46 0.0415
2022-08-12 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,443 13,443 148 0.0167
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -20,744 -100.00 0 -100.00
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 20,744 12,254 144.33 396 89.47 0.0438
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,490 8,490 209 0.0250
2021-08-13 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -16,388 -100.00 0 -100.00
2021-05-14 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 16,388 16,388 519 0.0586
2020-11-13 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -13,051 -100.00 0 -100.00
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,051 13,051 358 0.0539
2020-05-13 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -8,409 -100.00 0 -100.00
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,409 8,409 233 0.0373
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -29,085 -100.00 0 -100.00
2019-05-13 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 29,085 29,085 277 0.0454
2019-02-13 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -25,033 -100.00 0 -100.00
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 25,033 25,033 282 0.0392
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -17,143 -100.00 0 -100.00
2017-11-08 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 17,143 17,143 133 0.0216
2017-02-13 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 0 -11,088 -100.00 0 -100.00
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 11,088 11,088 91 0.0244
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.